Factor IX complex (Grifols)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFactor IX complex (Grifols)
Drug Alias Name人凝血因子IX复合物Profilnine
ClassificationBiologics > Protein drugs > Non-recombinant coagulation factorBiologics > Blood components > Non-recombinant coagulation factor
Mechanisms of ActionCoagulation factor VII modulatorsCoagulation factor X modulatorsCoagulation factor IX modulators +[4] 
TargetsCoagulation factor VIIProthrombinCoagulation factor IX +[4] 
Therapy Area/IndicationsHemophilia BIntracranial Hemorrhages
Global Approved IndicationsHemophilia B
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1981/07/21
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGrifols Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUtah State University
Active IndicationsHemophilia B
Inactive IndicationsIntracranial Hemorrhages

Other Information

ATC CodeB02BD01
Related LinksDrugBank